ITGAL and psoriasis: Indeed, preventing the egress of T cells from secondary lymphoid organs by S1P1 agonists or inhibiting T cell recruitment into the inflammatory sites by integrin (CD11a) blockade effectively ameliorates psoriasis (45, 46).